Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal Cancer

✍ Scribed by Weickhardt, A. J.; Price, T. J.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T. G.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A. M.; Mariadason, J. M.; Tebbutt, N. C.

• Book ID: 125850037
• Publisher: American Society of Clinical Oncology
• Year: 2012
• Tongue: English
• Weight: 240 KB
• Volume: 30
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2011.38.6599